1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Antiviral Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2024

Antiviral Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2024

  • April 2018
  • 100 pages
  • ID: 5112180
  • Format: PDF
  • By Infinium

Summary

Table of Contents

The report on global antiviral drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024.

The report predicts the global antiviral drugs market to grow with a cagr between 4.1 % from 2017 to 2024. The global antiviral drugs market was worth USD 43.01 billion tons in 2016.the study on antiviral drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, And Rest Of The World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.

The report on global antiviral drugs market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global antiviral drugs market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global antiviral drugs market. Porter’s five forces model in the report provides insights into the competitive rivalry in the global antiviral drugs market over the period of 2015 – 2023. Further, IGR-growth matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research methodology

• Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

• Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include
• Company reports and publications
• Government/institutional publications
• Trade and associations’ journals
• Databases such as WTO, OECD, and Worldbank, among others.
• Websites and publications by research agencies

Report Findings
1) Drivers
• Increase in incidences of epidemic viral infection.
• Strong research and development activities in order to develop advance drugs.
• Combination therapies in order to treat infection.
2) Restraints
• High cost of research and development in order to develop new drugs along with high risk of failure and stringent government regulations.
3) Opportunities
• Increasing incidences of epidemics in viral infection expected to provide massive growth opportunities.

Segments Covered
1) Global Antiviral Drugs Market
a. By Drug Type
• Generic
• Branded

b. By Therapeutics
• HIV/AIDS Therapeutics
• Hepatitis (B & C) Therapeutics
• Herpes Therapeutics
• Influenza Therapeutics
• Others (Pneumonia)

c. By Medicated End User
• Hospitals
• Clinics
• Ambulatory surgical Centres

2) Global Antiviral Drugs Market by Region
a. North America
b. Europe
c. Asia Pacific
d. Row

Companies Profiled:
• Roche Holding AG
• GlaxoSmithKline
• Bristol-Myers-Squibb
• Abbott Healthcare
• Med Immune/AstraZeneca
• Johnson & Johnson
• Merck & Co
• Gilead Sciences
• Cipla
• Dr Reddy

Reasons to buy this report
1) Comprehensive analysis of global as well as regional markets of antiviral drugs.
2) Complete coverage of all the product type and applications segments to analyze the trends, developments in Antiviral Drugs market, and forecast of market size up to 2023.
a. Comprehensive analysis of the companies operating in antiviral drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
3) Infinium Global Research - Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4795)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H2 2019

Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H2 2019’; Probable ...

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020" provides an overview ...

C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019

C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2019’; C-C Chemokine Receptor Type 5 (CHEMR13 ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on